Hepion Pharmaceuticals Inc. buy krebskrebs
Start price
31.05.21
/
50%
€27.14
Target price
31.05.22
€60.00
Performance (%)
-47.62%
End price
01.06.22
€14.22
Summary
This prediction ended on 01.06.22 with a price of €14.22. The BUY prediction by krebskrebs for Hepion Pharmaceuticals Inc. performed very badly with a performance of -47.62%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Hepion Pharmaceuticals Inc. | - | - | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
Comments by krebskrebs for this prediction
In the thread Hepion Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 3,0
In the thread Trading Hepion Pharmaceuticals Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten